The main concern regarding the tissue microarray technique is that 0.6-mm biopsies of tumor specimens on an array may not be representative of the whole tumor specimen because of tissue heterogeneity.

Chromosomal microarray analysis (CMA), one of the most frequently used microarray technologies in clinical laboratories, detects chromosomal losses and gains throughout the genome by comparing the ...

And as scientists use Phenotype MicroArray technology to explore advantages of diverse non-CHO animal cells, it is likely that some may be found to offer growth, productivity, ...

A DNA microarray (also commonly known as gene chip, DNA chip, or biochip) is a collection of microscopic DNA spots attached to a solid surface. Scientists use DNA microarrays to measure the ...

A protein microarray consists of the immobilization of proteins in organized rows and columns upon a support structure. The structure of the protein microarray allows for high-throughput analysis ...

A protein microarray is a piece of glass on which different molecules of protein have been affixed at separate locations in an ordered manner thus forming a microscopic array. These are used to ...

The first microarray scanner, built in 1989 by Stephen Fodor and colleagues at Affymax, was a table-sized, home-built affair that included a Zeiss confocal microscope, a laser, and several mirrors.

Novel high-density microarray patch (HD-MAP) can deliver vaccines directly to the skin Publication in PLoS Medicine reveals groundbreaking clinical research on broad potential of novel high ...

A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

Arrayjet provides microarray instruments and services to the pharmaceutical, diagnostic and life science industries. Our unique inkjet platform combines the fastest and most reliable instrumentation ...

On microarray analysis of tumors from the 125 patients, 485 of 672 genes had a coefficient of variation greater than 3% and were thus included in the analyses.

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from ...